Published in Vaccine Weekly, November 17th, 2010
The present Competitive Intelligence Report about Complement C5a & C5a Receptor Antagonists provides a competitor evaluation in the field of R&D projects of antagonists used to interfere with the interaction of complement C5a and its receptor for the treatment of inflammatory diseases as of October 2010. The molecules used to antagonize the interaction of C5a with C5aR include antibodies, proteins, peptides, nucleic acid macromolecules such as aptamers, vaccines and small...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly